HealthDay News — The US Food and Drug Administration is urging all patients with smartphone-compatible diabetes devices to check their phone configurations to ensure all safety alerts are being ...

HealthDay News — Among simple congenital heart diseases (CHD), patent foramen ovale (PFO) is associated with a significantly higher risk for epilepsy, according to a study published in the February ...

The Trump administration’s censorship has extended beyond federal websites and datasets to include research to be published in academic journals.

Nichols’ legacy serves as a reminder that although strides have been made toward inclusion, there is more that can be done to increase representation in the profession.

The NIH said capping indirect cost payments will save billions of dollars. Universities said it will disrupt vital, life-saving research.

Compared with adults aged 65 and older, those aged 18 to 64 are more affected by long COVID neurologic symptoms.

Emblaveo is a fixed-dose IV treatment that combines aztreonam, a monobactam antibiotic, and avibactam, a β-lactamase inhibitor.

Three recommendations suggest monotherapy options for preventing episodic migraine headache in outpatient settings ...

During the study, there was a steady increase in the PARF for CUD associated with schizophrenia, with no accelerations observed after cannabis policy changes. After medical cannabis liberalization, ...

Researchers sought to examine outcomes following in-hospital cardiac arrest among Hispanic and Asian patients.

Dementia cases had lower BMI and waist circumference and faster declines; HDL levels generally higher predementia ...

The Food and Drug Administration (FDA) has approved Avtozma ® (tocilizumab-anoh), a biosimilar to Actemra ® (tocilizumab), in both intravenous (IV) and subcutaneous (SC) formulations.